Pathogenetic and therapeutic applications of microRNAs in major depressive disorder
Author:
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 64, 341-348
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health (R01MH082802, R21MH081099, R21MH091509, 1R01MH101890, R01MH100616)
- American Foundation for Suicide Prevention (SRG-XXXX-001778-1209)
- Center for Advancing Translational Sciences, National Institutes of Health (UL1TR000050)
This publication has 112 references indexed in Scilit:
- Alterations of Serum Levels of BDNF-Related miRNAs in Patients with DepressionPLOS ONE, 2013
- MicroRNAs in Stress Signaling and Human DiseaseCell, 2012
- Evidence demonstrating role of microRNAs in the etiopathology of major depressionJournal of Chemical Neuroanatomy, 2011
- MicroRNA networks direct neuronal development and plasticityCellular and Molecular Life Sciences, 2011
- Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmissionNeurobiology of Disease, 2011
- An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signalingMolecular and Cellular Neuroscience, 2010
- Changes in Brain MicroRNAs Contribute to Cholinergic Stress ReactionsJournal of Molecular Neuroscience, 2009
- Neuronal activity rapidly induces transcription of the CREB‐regulated microRNA‐132, in vivoHippocampus, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009